Oyster Point Pharma Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Oyster Point Pharma Inc (OYST) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Oyster Point Pharma Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 20M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+14.2% annualized vs trailing 12 months).
- Peer revenue share: Oyster Point Pharma Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
OYST Sales vs. its Competitors, Q3 2022
Oyster Point Pharma Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Biotechnology & Pharmaceuticals industry grew revenue 20.7% year over year, combined, vs -68.8% for Oyster Point Pharma Inc. Oyster Point Pharma Inc's share of combined industry revenue moved from 0.05% to 0.01%, a loss of 0.04 percentage points.